Many Dermatology Guideline Authors Get Industry Payments

Share this content:
Many Dermatology Guideline Authors Get Industry Payments
Many Dermatology Guideline Authors Get Industry Payments

WEDNESDAY, Oct. 18, 2017 (HealthDay News) -- Many authors of dermatology clinical practice guidelines receive industry payments, and these payments are often not accurately disclosed, according to a study published online Oct. 18 in JAMA Dermatology.

Jake X. Checketts, from Oklahoma State University in Tulsa, and colleagues retrieved three American Academy of Dermatology guidelines published from 2013 to 2016. The Open Payments database was used to identify financial payments received by 49 guideline authors.

The researchers found that 40 of the 49 authors received at least one reported industry payment; 31, 25, and 18 accepted more than $1,000, more than $10,000, and more than $50,000, respectively. Per author, financial payments amounted to a mean of $157,177. Among the 49 authors, the total reimbursement was $7,701,681 from 2013 to 2015. Twenty-two of the 40 authors who received payments did not accurately disclose industry relationships. The authors received payments from companies with products directly related to the guideline topics. There were violations to the administrative regulations.

"Dermatology clinical practice guideline authors received sizable industry payments and did not completely disclose these payments," the authors write. "The American Academy of Dermatology policies may benefit from stricter enforcement or the adoption of new standards."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

High Costs Associated With Physician Burnout, Attrition

High Costs Associated With Physician Burnout, Attrition

Economic loss at Stanford over two years expected to range from $15.5 million to $55.5 million

Insulin Doesn't Prevent Diabetes in Relatives of T1DM Patients

Insulin Doesn't Prevent Diabetes in Relatives of T1DM ...

Oral insulin doesn't delay onset in autoantibody-positive relatives of patients with type 1 diabetes

Workplace Sexual Harassment Ongoing in Women, Up for Men

Workplace Sexual Harassment Ongoing in Women, Up for ...

Women report more adverse effects after SH than men, but SH can trigger depression, anxiety in men

is free, fast, and customized just for you!

Already a member?

Sign In Now »